Drug Profile
Research programme: NMDA receptor antagonists - Gedeon Richter
Alternative Names: N-methyl-D-aspartate receptor agonists - Gedeon RichterLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain; Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neuropathic-pain in Hungary
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in Hungary
- 26 Jul 2010 Preclinical development is ongoing in Hungary